First Trust NYSE Arca Biotechnology Index Fund Rating $247.39 -1.43 (-0.57%) Closing price 07/24/2026 04:10 PM EasternExtended Trading$247.48 +0.10 (+0.04%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.65Holdings in FBT have an aggregate rating of Moderate Buy based on 477 analyst ratings issued in the past year covering 25 companies (88.1% of the portfolio).FBT Aggregate Price Target$247.39High Prediction$247.39Average Prediction$247.39Low Prediction$247.39Holdings in FBT have an aggregate price target of $247.39 and a range of $247.39 to $247.39 covering 25 companies (88.1% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FBT Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.77%CORTCorcept Therapeutics$95.36-1.3%2.2498 of 5 stars2.75$88.83 -6.8%8News CoverageUpcoming Earnings5.17%VCYTVeracyte$56.61-2.2%1.8026 of 5 stars2.60$55.88 -1.3%10Upcoming Earnings5.09%NEONeoGenomics$13.89-2.5%1.6235 of 5 stars2.42$14.57 4.9%12News CoverageUpcoming EarningsAnalyst Forecast4.21%BRKRBruker$60.45-2.7%2.3949 of 5 stars2.44$56.79 -6.1%164.21%ALKSAlkermes$52.89-0.2%2.2208 of 5 stars2.72$52.50 -0.7%18News CoveragePositive NewsUpcoming Earnings4.18%ILMNIllumina$194.09-1.4%2.3455 of 5 stars2.37$156.88 -19.2%19Trending NewsUpcoming Earnings3.88%NTRANatera$261.99-1.0%3.2615 of 5 stars2.82$267.83 2.2%223.65%KRYSKrystal Biotech$335.19+2.3%3.1382 of 5 stars2.83$360.67 7.6%12News CoveragePositive News3.60%NBIXNeurocrine Biosciences$175.77+0.9%4.5152 of 5 stars2.96$194.05 10.4%23News CoveragePositive NewsUpcoming EarningsAnalyst Forecast3.60%AXSMAxsome Therapeutics$241.00-0.2%2.7169 of 5 stars2.91$261.48 8.5%23Positive News3.48%TECHBio-Techne$71.60-0.2%2.6705 of 5 stars2.12$68.08 -4.9%17Positive News3.39%EXELExelixis$55.37-0.5%2.8766 of 5 stars2.40$49.00 -11.5%20News CoveragePositive NewsAnalyst Forecast3.33%RGENRepligen$131.96-4.1%4.0677 of 5 stars2.88$165.36 25.3%17News CoverageUpcoming Earnings3.24%INCYIncyte$117.67+0.8%3.1786 of 5 stars2.36$111.10 -5.6%22News CoverageUpcoming EarningsAnalyst Forecast3.08%BIIBBiogen$202.19+0.8%3.9219 of 5 stars2.53$220.57 9.1%32Upcoming EarningsAnalyst Forecast3.02%HALOHalozyme Therapeutics$81.93+1.3%3.1511 of 5 stars2.54$81.60 -0.4%13News CoverageAnalyst Forecast2.98%ARWRArrowhead Pharmaceuticals$85.60-1.4%1.8999 of 5 stars2.71$93.83 9.6%14News CoverageAnalyst Forecast2.95%VRTXVertex Pharmaceuticals$477.36+0.9%4.2749 of 5 stars2.88$559.61 17.2%25Positive News2.92%BMRNBioMarin Pharmaceutical$59.33+0.8%4.5077 of 5 stars2.71$88.26 48.8%24News CoveragePositive News2.91%ARGXargenex$918.22-0.7%4.0691 of 5 stars2.92$1,050.50 14.4%24Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.78%GMABGenmab A/S$28.87-1.0%4.7911 of 5 stars2.77$39.28 36.1%13Analyst Upgrade2.76%AMGNAmgen$376.04+1.2%4.0343 of 5 stars2.43$356.62 -5.2%30Positive News2.71%ONCBeOne Medicines$325.90-0.3%4.2677 of 5 stars2.80$394.00 20.9%15Trending NewsAnalyst Forecast2.60%BNTXBioNTech$89.33-3.0%4.1878 of 5 stars2.74$129.13 44.5%192.56%GILDGilead Sciences$129.31-1.2%4.9229 of 5 stars2.86$158.33 22.4%29Analyst Downgrade This page (NYSEARCA:FBT) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored“The unseen winner of the AI race” is not SpaceXMarc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...Chaikin Analytics | SponsoredBlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
